Edge Wealth Management LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
Edge Wealth Management LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$68,000
-41.4%
4,1750.0%0.01%
-47.8%
Q3 2021$116,000
-6.5%
4,1750.0%0.02%
-8.0%
Q2 2021$124,000
+6.0%
4,1750.0%0.02%0.0%
Q1 2021$117,000
-2.5%
4,1750.0%0.02%
-7.4%
Q4 2020$120,000
+14.3%
4,1750.0%0.03%
+12.5%
Q3 2020$105,000
-9.5%
4,175
-12.1%
0.02%
+9.1%
Q2 2020$116,000
+65.7%
4,7500.0%0.02%
+46.7%
Q1 2020$70,000
-9.1%
4,7500.0%0.02%0.0%
Q4 2019$77,000
+83.3%
4,750
+46.2%
0.02%
+50.0%
Q3 2019$42,0000.0%3,2500.0%0.01%
+11.1%
Q2 2019$42,000
-17.6%
3,2500.0%0.01%
-30.8%
Q1 2019$51,000
+410.0%
3,250
+550.0%
0.01%
+333.3%
Q4 2018$10,000
-16.7%
5000.0%0.00%0.0%
Q3 2018$12,000
-14.3%
5000.0%0.00%
-25.0%
Q2 2018$14,000
-6.7%
5000.0%0.00%0.0%
Q1 2018$15,0005000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders